This company listing is no longer active
Goodbody Health Crecimiento futuro
Future controles de criterios 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Goodbody Health.
Información clave
-2.3%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Pharmaceuticals | 14.9% |
| Tasa de crecimiento de los ingresos | -81.4% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 24 Nov 2022 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2023 | 5 | -4 | -4 | -4 | 1 |
| 12/31/2022 | 11 | -4 | N/A | -5 | 1 |
| 9/30/2022 | 16 | -4 | -1 | -1 | N/A |
| 6/30/2022 | 20 | -2 | 0 | 1 | N/A |
| 3/31/2022 | 21 | -2 | 2 | 2 | N/A |
| 12/31/2021 | 17 | -2 | 2 | 2 | N/A |
| 9/30/2021 | 11 | -3 | -1 | -1 | N/A |
| 6/30/2021 | 6 | -4 | -2 | -2 | N/A |
| 3/31/2021 | 3 | -5 | -2 | -2 | N/A |
| 12/31/2020 | 2 | -5 | -3 | -2 | N/A |
| 9/30/2020 | 2 | -5 | -2 | -2 | N/A |
| 6/30/2020 | 2 | -5 | -3 | -3 | N/A |
| 3/31/2020 | 2 | -4 | N/A | N/A | N/A |
| 12/31/2019 | 1 | -4 | -3 | -3 | N/A |
| 9/30/2019 | 1 | -3 | -3 | -3 | N/A |
| 6/30/2019 | 1 | -3 | -3 | -3 | N/A |
| 3/31/2019 | 1 | -2 | N/A | N/A | N/A |
| 12/31/2018 | 0 | -2 | -2 | -2 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: GDBY is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: GDBY is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: GDBY is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: GDBY's revenue is expected to decline over the next 3 years (-81.4% per year).
Ingresos de alto crecimiento: GDBY's revenue is forecast to decline over the next 3 years (-81.4% per year).
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if GDBY's Return on Equity is forecast to be high in 3 years time